Society for Translational Oncology: A Global Mission

The Society for Translational Oncology (STO) is a 501(c)(3) not-for-profit organization that promotes high-quality, equitable patient care and fosters the discovery and clinical translation of important new therapies that enhance the practice of global oncology as well as supports the prevention and treatment of infectious diseases that impact cancer patients and others with weakened immune systems, thus helping protect the vulnerable from life-threatening infections.

STO bridges a translational gap between drug discovery and approved drug delivery with a portfolio of educational activities for physicians and other members of the healthcare team.

STO’s decades-long commitment to translational research and education includes fellowships in both cancer and infectious diseases. The latter has become a critical STO commitment during the COVID-19 pandemic from the global genesis to worldwide distribution of new vaccines and improved therapeutics.

STO Continuing Medical Education Mission

Healthcare professionals are continuously charged with staying on the cutting edge of new medical treatments and technologies. As a professional association dedicated to the continuing education of oncology and hematology/oncology professionals, STO helps improve the quality, safety and equity of caring for cancer patients and others with weakened immune systems by ensuring the following expected results are fulfilled:

  • Knowledge and strategies for implementation of critical new developments in cancer treatment are brought forth to community oncology care teams
  • The translational gap between discovery and delivery of care to the patient is bridged by providing content that is evidence-based and falls within the discipline of clinical medicine
  • Continuing medical education activities are relevant and impact the professional practice of physicians, nurses, pharmacists and other members of healthcare teams who not only treat patients with cancer but others with weakened immune systems
  • Activities impact the performance of physicians and other interprofessional care team members and sustain change and/or foster improvements that positively impact the equitable provision of care